Yangtze Optical Fibre And Cable Joint Stock Limited Company (HKG:6869)

Market Cap	31.60B
Revenue (ttm)	13.62B
Net Income (ttm)	825.20M
Shares Out	752.91M
EPS (ttm)	1.07
PE Ratio	24.99
Forward PE	20.22
Dividend	0.29 (1.08%)
Ex-Dividend Date	Jul 3, 2025

Volume	22,708,500
Average Volume	26,883,341
Open	27.50
Previous Close	27.05
Day's Range	25.85 - 27.95
52-Week Range	7.57 - 30.25
Beta	0.04
RSI	70.82
Earnings Date	Aug 30, 2025

About Verve Therapeutics

Yangtze Optical Fibre And Cable Joint Stock Limited Company engages in the production and sale of optical fiber preforms, optical fiber, optical fiber cables, and integrated solutions in China and internationally. The company provides cutting edge products; optical fiber preforms, coating, and silicon tetrachloride; quartz mineral; communication optical fire; cable products; specialty fibers, optical fiber components and modules, optical assemblies and modules, and optical fiber sensing system; submarine fiber-optic cable; optical transceiver; ...

• Industry: Communication Equipment
• Sector: Technology
• Founded: 1988
• Employees: 4,358
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6869

Financial Performance

In 2024, HKG:6869's revenue was 12.20 billion, a decrease of -8.65% compared to the previous year's 13.35 billion. Earnings were 675.88 million, a decrease of -47.91%.